[Treatment of rheumatoid arthritis with imidazole-2-hydroxybenzoate or naproxen: study of the efficacy and tolerability].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use*; D012459:Salicylates
D000893:Anti-Inflammatory Agents; D007093:Imidazoles; D012459:Salicylates; C043292:imidazole-2-hydroxybenzoate; D009288:Naproxen
Trattamento dell'artrite reumatoide con imidazolo-2-idrossibenzoato o naproxen: studio di efficacia e tollerabilitá.